0001062993-13-005972.txt : 20131120
0001062993-13-005972.hdr.sgml : 20131120
20131120160223
ACCESSION NUMBER: 0001062993-13-005972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131118
FILED AS OF DATE: 20131120
DATE AS OF CHANGE: 20131120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gitman Paul
CENTRAL INDEX KEY: 0001375378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 131232976
MAIL ADDRESS:
STREET 1: 167 EXECUTIVE DRIVE
CITY: MANHASSET HILLS
STATE: NY
ZIP: 11040
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2013-11-18
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375378
Gitman Paul
167 EXECUTIVE DRIVE
MANHASSET HILLS
NY
11040
1
0
0
0
Common Stock, $0.001 par value
2013-11-18
4
S
0
7000
22
D
59425
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2013.
/s/ Paul Gitman by Carl A. Valenstein, attorney in fact
2013-11-20